CPT-11 - The European experience

被引:11
作者
Armand, JP
Terret, C
Couteau, C
Rixe, O
机构
来源
CAMPTOTHECINS: FROM DISCOVERY TO THE PATIENT | 1996年 / 803卷
关键词
D O I
10.1111/j.1749-6632.1996.tb26398.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:282 / 291
页数:10
相关论文
共 34 条
[1]   PHASE-I AND PHARMACOLOGICAL STUDIES OF THE CAMPTOTHECIN ANALOG IRINOTECAN ADMINISTERED EVERY 3 WEEKS IN CANCER-PATIENTS [J].
ABIGERGES, D ;
CHABOT, GG ;
ARMAND, JP ;
HERAIT, P ;
GOUYETTE, A ;
GANDIA, D .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :210-221
[2]   IRINOTECAN (CPT-11) HIGH-DOSE ESCALATION USING INTENSIVE HIGH-DOSE LOPERAMIDE TO CONTROL DIARRHEA [J].
ABIGERGES, D ;
ARMAND, JP ;
CHABOT, GG ;
DACOSTA, L ;
FADEL, E ;
COTE, C ;
HERAIT, P ;
GANDIA, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (06) :446-449
[3]   CPT-II (IRINOTECAN) IN THE TREATMENT OF COLORECTAL-CANCER [J].
ARMAND, JP ;
DUCREUX, M ;
MAHJOUBI, M ;
ABIGERGES, D ;
BUGAT, R ;
CHABOT, G ;
HERAIT, P ;
DEFORNI, M ;
ROUGIER, P .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (7-8) :1283-1287
[4]  
BONNETERRE J, 1995, B CANCER, V82, P623
[5]  
BONNETERRE J, 1993, P AM SOC CLIN ONCOL, V12, P179
[6]  
BUGAT R, 1995, 5 INT C ANT CHEM PAR
[7]   PHASE-I AND PHARMACOKINETIC STUDY OF IRINOTECAN (CPT-11) ADMINISTERED DAILY FOR 3 CONSECUTIVE DAYS EVERY 3 WEEKS IN PATIENTS WITH ADVANCED SOLID TUMORS [J].
CATIMEL, G ;
CHABOT, GG ;
GUASTALLA, JP ;
DUMORTIER, A ;
COTE, C ;
ENGEL, C ;
GOUYETTE, A ;
MATHIEUBOUE, A ;
MAHJOUBI, M ;
CLAVEL, M .
ANNALS OF ONCOLOGY, 1995, 6 (02) :133-140
[8]   POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF IRINOTECAN (CPT-11) AND ACTIVE METABOLITE SN-38 DURING PHASE-I TRIALS [J].
CHABOT, GG ;
ABIGERGES, D ;
CATIMEL, G ;
CULINE, S ;
DEFORNI, R ;
EXTRA, JM ;
MAHJOUBI, H ;
HERAIT, P ;
ARMAND, JP ;
BUGAT, R ;
CLAVEL, M ;
MARTY, ME .
ANNALS OF ONCOLOGY, 1995, 6 (02) :141-151
[9]   DNA TOPOISOMERASES - ESSENTIAL ENZYMES AND LETHAL TARGETS [J].
CHEN, AY ;
LIU, LF .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 :191-218
[10]  
CHEVALLIER B, 1995, 8 EUR C CLIN ON CANC, pS246